منابع مشابه
Some Things Must Not Change.
The past three months have been a season of tremendous change, and many of us have been surprised by the political events that have taken place. January heralds a change in administration for the United States, and the future seems uncertain. I sense that change is going to be the new normal, and we have to be able to cope with it-and with each other-for a long time. What I want to talk about i...
متن کاملSome Have a Talent for Bargaining and Some Dont
In Bargaining Theory players di¤er from one another in either their valuation for the negotiated object and/or their time preferences. We suggest a model that incorporates "bargaining ability" as another source for heterogeneity across players. This bargaining ability for the buyer determines how many o¤ers he will be able to turn down before he walks away. For the seller this ability determine...
متن کاملSome Things Algorithms Cannot Do
A new, ‘behavioral’ theory of algorithms, intending to capture algorithms at their intended abstraction level, has been developed in this century in a series of papers by Y. Gurevich, A. Blass and others, motivated initially by the goal of establishing the ASM thesis. A viable theory of algorithms must have its limitative results, algorithms, however abstract, cannot do just anything. We establ...
متن کاملPerspectives in Pharmacology Drugs Targeting Alzheimer’s Disease: Some Things Old and Some Things New
Enormous effort is now being devoted to developing drugs that slow neurodegeneration in Alzheimer’s disease (AD), although insights into AD genetics and molecular pathogenesis only arose in the last 15 years. Acetylcholinesterase inhibitors that temporarily slow loss of cognitive function remain the only approved AD drugs. Discovery of mutations in three genes leading to severe early onset AD w...
متن کاملDrugs targeting Alzheimer's disease: some things old and some things new.
Enormous effort is now being devoted to developing drugs that slow neurodegeneration in Alzheimer's disease (AD), although insights into AD genetics and molecular pathogenesis only arose in the last 15 years. Acetylcholinesterase inhibitors that temporarily slow loss of cognitive function remain the only approved AD drugs. Discovery of mutations in three genes leading to severe early onset AD w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oceanography
سال: 2008
ISSN: 1042-8275
DOI: 10.5670/oceanog.2008.41